What´s new in PubMed this week
The robotic-assisted extended “Sistrunk” approach for tumors of the upper aerodigestive tract with limited transoral access: First description of oncological and functional outcomes. Simon C, Beharry A, Paleri V, Dübi P, Lambercy K, Holsinger FC, Todic J. Head Neck. 2022 Jun 2. doi: 10.1002/hed.27114. Online ahead of print. PMID: 35656594
A prospective cohort study with 6 patients. A new procedure to improve exposure was used in patients with head&neck cancer and limited transoral access.
Long-term results of robotic-assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma. Tsang RK, Chan WCP, Holsinger FC, Chung JCK, Chow VLY, Chan JYW, Ho WK, Wei WI. Head Neck. 2022 Jun 1. doi: 10.1002/hed.27115. Online ahead of print. PMID: 35642444
Five-year follow-up data of thirty -one patients with salvage surgery for recurrent nasopharyngeal carcinoma. Overall survival: 55,7%
Robotic Neck Dissection in Head and Neck Cancer: A safe perception or deception? Subash A, Bylapudi B, Thakur S, Rao VUS. Br J Oral Maxillofac Surg. 2022 Apr 22:S0266-4356(22)00128-0. doi: 10.1016/j.bjoms.2022.02.007. Online ahead of print. PMID: 35641375
The on-going debate on robotic neck dissection…
Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes. Warner L, O’Hara JT, Lin DJ, Oozeer N, Fox H, Meikle D, Hamilton D, Iqbal MS, Robinson M, Paleri V. Oral Oncol. 2022 May 26;130:105909. doi: 10.1016/j.oraloncology.2022.105909. Online ahead of print. PMID: 35636080
Again, outcomes of “TORS alone” (surgery alone, no chemo, no radiaton theraphy) series. Fifty-one patients treated with curative intent for HNSCC, with TORS and ND alone. With a median follow up of 43 months, estimated 3-years local control: 92%. London series.